Company: PGEN
Filing Date: 2025-05-14
Form Type: 10-Q
Source: 0001356090-25-000019
Chunk: 76

Company: PRECIGEN, INC.
Filing Date: 2025-05-14
Form: 10-Q
Item: Part I, Item 8
Chunk 76
---
 awards, to employees, officers, consultants, advisors, and nonemployee directors.  Upon the effectiveness of the Company's 2023 Omnibus Incentive Plan, as amended (the "2023 Plan") in June 2023, no new awards may be granted under the 2013 Plan and any awards granted under the 2013 Plan prior to the effectiveness of the 2023 Plan will remain outstanding under such plan and will continue to vest and/or become exercisable in accordance with their original terms and conditions. As of March 31, 2025, there were 15,704,897 stock options and no RSUs outstanding under the 2013 Plan.In April 2023, Precigen adopted the 2023 Plan, which became effective upon shareholder approval in June 2023. The 2023 Plan permits the grant of share-based awards, including stock options, restricted stock awards, RSUs, PSUs  and other awards, to officers, employees and nonemployees. The 2023 Plan authorizes for issuance pursuant to awards under the 2023 Plan an aggregate of 18,418,137 shares, which included shares remaining available for issuance under the 2013 Plan as of the adoption of the 2023 Plan plus an increase of  2,000,000 shares of common stock, which was approved by Precigen's shareholders at Precigen's annual meeting on July 5, 2024. As of March 31, 2025, there were 5,756,083 stock options, 1,654,000 PSUs and no RSUs outstanding under the 2023 Plan and 7,510,697 shares were available for future grants.  In April 2019, Precigen adopted the 2019 Incentive Plan for Non-Employee Service Providers (the "2019 Plan"), which became effective upon shareholder approval in June 2019. The 2019 Plan permits the grant of share-based awards, including stock 

21

options, restricted stock awards, and RSUs, to non-employee service providers, including board members. As of March 31, 2025, there were 12,000,000 shares authorized for issuance under the 2019 Plan, of which 4,437,701 stock options and 773,311 RSUs were outstanding and 747,272 shares were available for future grants. Stock option activity was as follows:Number of SharesWeighted Average Exercise PriceWeighted Average Remaining Contractual Term (